- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Austin Frakt Suggests Ways of Improving Healthcare Transparency
Providing the cost of care beforehand will allow the patient enough time to understand what he or she may be getting into, similar to signing a contract, according to Austin Frakt, PhD, health economist and researcher.
When it comes to cost and prices in healthcare, Austin Frakt, PhD, health economist and researcher, believes that providing the cost of care beforehand will allow the patient enough time to understand what he or she may be getting into, as if it were like signing a contract.
He adds that the quality side of the industry should mirror its cost-related counterparts.
“I think it’s really just an ethical issue that patients should know what they’re paying for what they’re getting,” Dr Frakt says. He added that “If you buy any other product—a cell phone, a car, a computer—you want to know the price and how it’s going to perform and I think we should know that in healthcare as well.”
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
